Phenotypic characteristics of a novel mutation rtM204Q in the reverse-transcriptase domain of hepatitis B virus isolated from a chronic hepatitis B patient receiving lamivudine treatment
Yan Wang,Yan Liu,Zhi-hui Xu,Lan-lan Si,Li Chen,J. Dai,Z. Yao,Dong-ping Xu
2012-01-06
Abstract:Objective To analyze the phenotypic characteristics of a novel mutation rtM204Q in the reverse-transcriptase (RT) domain of hepatitis B virus (HBV). Methods HBV DNA was isolated from a chronic hepatitis B patient receiving lamivudine treatment. The full-length RT region was amplified and the PCR product was cloned into the pGEM-Teasy vector. About 40 clones were randomly selected for DNA sequencing and drug-resistance-associated variation was analyzed. After restriction enzyme (XhoⅠ/SphⅠ) digestion and ligation procedure, the 1.1-ploid genome length HBV recombinant plasmids harboring wild type and three different mutants in RT region were constructed. Then the replication-competent constructs pTriEx–wRT and pTriEx–mRT were transiently transfected into the HepG2 cells by FuGene® HD transfection reagent. Four hours post-transfection, new media containing different concentrations of nucleoside/nucleotide analogs (lamivudine: 0, 0.01, 0.1, 1, 10, 100μmol/L; adefovir: 0, 0.033, 0.1, 0.33, 1, 3.3μmol/L; entecavir: 0, 0.001, 0.01, 0.1, 1, 10μmol/L; tenofovir: 0, 0.01, 0.1, 1, 10, 100μmol/L) were sequentially replaced every other day for 4 days. To analyze the phenotypic characteristics of the HBV mutant with different concentrations of the drug, the supernatant was collected and HBV DNA quantitation was done using real-time PCR. Results Sequence analysis of 37 clones showed that there were five mutants in RT region, 13 (35.1%) for wild type, 11 (29.7%) for rtM204Q, 2 (5.4%) for rtM204I, 10 (27.0%) for rtA181T, and 1 (2.7%) for rtA181T + rtM204Q. The relative replication capacity of the latter four mutants was 89.95%, 46.28%, 55.77% and 34.44% (P < 0.05) of wild-type strain, respectively. Phenotypic resistance analysis of the former two mutants showed that susceptibility of rtM204Q and rtM204I strains to lamivudine was 1/75.68 and 1/1000 respectively compared to the wild type strain, while their susceptibility to adefovir, entecavir and tenofovir maintained unchanged. Conclusion The novel variation pattern rtM204Q in HBV YQDD motif could inhibit the replication capacity to some extent and present a less susceptibility to lamivudine, indicating that rtM204Q might be a novel lamivudine-resistant mutation.
Biology